American Tungsten Corp. (TSXV: TUNG, OTCQB: DEMRF)
Building America’s Defense Critical Metals Supply
Just one month ago, AI chip company Cerebras Systems (CBRS) made its Nasdaq debut at an IPO price of $185. On its first trading day, the stock soared to $350 at the open, hitting an intraday peak of $386.34 and pushing its market capitalization past the $100 billion mark. However, the euphoria quickly faded – by June 15, the stock had dropped to $201, down more than 42% from its opening price, with its market cap shrinking to approximately $44.1 billion from its peak.
The sharp pullback was driven by concerns over customer concentration and the path to profitability. Yet just as the stock nearly halved, Wall Street analysts made a rare synchronized move to turn bullish. On the same day, a host of major institutions – including Morgan Stanley, UBS, Wedbush, Rosenblatt, Mizuho, Barclays, and Citi – released their initial research reports on Cerebras, almost unanimously giving “Buy” or “Overweight” ratings. Price targets were clustered in the range of $250 to $340, with a consensus target of around $295.
The Differentiated Narrative of the “Wafer-Scale Chip”
The core logic behind Wall Street’s bullishness lies in Cerebras’ unique business path. The current AI computing market is dominated by Nvidia’s GPUs, but Cerebras has taken a different route, producing the world’s only commercially deployed wafer-scale processor, the WSE-3. This “largest-ever” chip integrates 4 trillion transistors and 900,000 AI-optimized cores, with 44GB of on-chip SRAM and 21 PB/s of memory bandwidth – thousands of times that of typical HBM solutions.
More importantly, this architecture fundamentally eliminates the “memory wall” bottleneck. Cerebras claims its system is up to 15 times faster than leading GPUs for most workloads, particularly well-suited for AI inference scenarios where low latency is critical.
Morgan Stanley noted that as AI workloads transition from the training phase to the inference phase, demand for fast, low-latency inference is growing rapidly. Wedbush believes Cerebras’ IPO timing coincides perfectly with this critical market cycle shift. Citi even predicts the company could capture 40% to 50% of the high-speed inference market.
Two Sides of the Same Coin: Performance and Risk
Cerebras’ revenue reached $510 million in 2025, up 76% year-over-year, and the company reported net income of $87.9 million, swinging from a loss of $485 million in 2024. Bank of America Merrill Lynch forecasts its earnings growth over the next year at 370%, surpassing Nvidia’s expected 195% for the same period.
However, risks are equally significant. First, customer concentration – in 2025, the UAE’s MBZUAI University contributed 62% of revenue, while G42 accounted for 24%, together representing 86% of total revenue. Even with a multi-year computing agreement with OpenAI valued at over $20 billion, the customer concentration risk has not been fundamentally resolved.
Second is valuation. At the current stock price, Cerebras trades at a P/E ratio of 225x. Although investment banks justify their price targets based on a 14x multiple of projected 2028 revenue of $6.8 billion, this valuation still rests on highly optimistic long-term expectations.
Conclusion
Cerebras’ story offers both the allure of technological disruption and the uncertainty of commercial monetization. For existing shareholders, the collective bullishness from Wall Street provides near-term sentiment support. But for those who have not yet entered, waiting for greater clarity – particularly until the customer base truly diversifies and the first quarterly report (expected on June 23) is released – may be the more prudent approach. The true quality of this “Nvidia challenger” will ultimately be validated by time and performance.
